9n9l
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 9n9l is ON HOLD | + | The entry 9n9l is ON HOLD until Paper Publication |
Authors: Spurlino, J.C., Milligan, C. | Authors: Spurlino, J.C., Milligan, C. | ||
| Line 7: | Line 7: | ||
Description: An RORgt Inverse agonist for treatment of Psoriasis | Description: An RORgt Inverse agonist for treatment of Psoriasis | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
| - | [[Category: Milligan, C]] | ||
[[Category: Spurlino, J.C]] | [[Category: Spurlino, J.C]] | ||
| + | [[Category: Milligan, C]] | ||
Revision as of 20:19, 26 March 2025
Unreleased structure
The entry 9n9l is ON HOLD until Paper Publication
Authors: Spurlino, J.C., Milligan, C.
Description: An RORgt Inverse agonist for treatment of Psoriasis
